Seda YILMAZ SEMERCİ, Sezer ACAR, MERİH ÇETİNKAYA, Burak YÜCEL, Osman Samet GÜNKAYA

The possible association between neonatal morbidities and amniotic fluid pH and electrolyte levels in infants of preeclamptic mothers

Background. Preeclampsia is a pregnancy-specific syndrome associated with increased perinatal mortality characterized by hypertension and proteinuria. An increasing number of studies have been published on the effect of preeclampsia on neonatal morbidities. However, there is no study regarding the possible effect of preeclampsia on amniotic fluid pH and electrolytes. The aim of this study was to determine the possible role of amniotic fluid pH and electrolytes for the prediction of and/or association with preeclampsia and neonatal morbidities. Methods. This was a prospective, case-control study. During cesarean section (C/S), 1 ml of amniotic fluid was aspirated before incision of membranes. Amniotic fluid pH and electrolytes were analyzed by blood gas machine and biochemistry laboratory concurrently. Maternal and neonatal demographic features and clinical outcomes, presence of respiratory morbidities were all recorded. Results. Amniotic fluid pH, sodium and gestational age were found to be independent risk factors for preeclampsia. Subgroup analysis revealed that in early onset preeclampsia group mechanical ventilation duration, duration of 02 therapy, sepsis and intrauterine growth retardation (IUGR) were higher than infants in control group born before 32 gestational weeks. Also, in the early onset preeclampsia group pH and potassium were higher compared with the control group. Conclusions. To the best of our knowledge, this is the first study that reported the value of amniotic fluid electrolyte analysis for the prediction of preeclampsia and neonatal morbidities in term and preterm infants. However, more studies including a larger number of infants are required to confirm the role of amniotic fluid analysis to predict preeclampsia and/or neonatal morbidities.

PDF

___

1. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol 2005; 25: 341-348.

2. Brace RA, Cheung CY. Regulation of amniotic fluid volume: evolving concepts. Adv Exp Med Biol 2014; 814: 49-68.

3. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with earlyversus late-onset disease. Am J Obstet Gynecol 2013; 209: 544.e1-544.e12.

4. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 2012; 5: 9-18.

5. Shanmugalingam R, Hennessy A, Makris A. Aspirin in the prevention of preeclampsia: the conundrum of how, who and when. J Hum Hypertens 2019; 33: 1-9.

6. Yılmaz Semerci S, Yücel B, Erbas IM, Gunkaya OS, Talmac M, Çetinkaya M. The utility of amniotic fluid pH and electrolytes for prediction of neonatal respiratory disorders. J Matern Fetal Neonatal Med 2020; 33: 253-257.

7. Suzuki M, Maekawa R, Patterson NE, et al. Amnion as a surrogate tissue reporter of the effects of maternal preeclampsia on the fetus. Clin Epigenetics 2016; 8: 67.

8. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156: 532-536.

9. Cetinkaya M, Ozkan H, Koksal N. Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. Early Hum Dev 2012; 88: 893-898.

10. Ozkan H, Cetinkaya M, Koksal N. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med 2012; 25: 2681-2685.

11. Pogorelova TN, Krukier II, Gunko VO, Nikashina AA, Alliluev IA, Larichkin AV. The imbalance of vasoactive components and arachidonic acid in the placenta and amniotic fluid in preeclampsia. Biomed Khim 2019; 65: 245-250.

12. Bilodeau JF. Review: maternal and placental antioxidant response to preeclampsia- impact on vasoactive eicosanoids. Placenta 2014; 35(Suppl): S32-S38.

13. Giannubilo SR, Tiano L, Ciavattini A, et al. Amniotic coenzyme Q10: is it related to pregnancy outcomes? Antioxid Redox Signal 2014; 21: 1582-1586.

14. Pogorelova TN, Gunko VO, Nikashina AA, Mikhelson AA, Alliluev IA, Mikhelson AM. Disbalance of redox processes in amniotic fluid at pre-eclampsia. Klin Lab Diagn 2018; 63: 483-489.

15. Banadakoppa M, Vidaeff AC, Yallampalli U, Ramin SM, Belfort MA, Yallampalli C. Complement split products in amniotic fluid in pregnancies subsequently developing early-onset preeclampsia. Dis Markers 2015; 2015: 263109.

16. Wolak T, Sergienko R, Wiznitzer A, Ben Shlush L, Paran E, Sheiner E. Low potassium level during the first half of pregnancy is associated with lower risk for the development of gestational diabetes mellitus and severe pre-eclampsia. J Matern Fetal Neonatal Med 2010; 23: 994-998.

17. Fotiou M, Michaelidou AM, Masoura S, et al. Second trimester amniotic fluid uric acid, potassium, and cysteine to methionine ratio levels as possible signs of early preeclampsia: a case report. Taiwan J Obstet Gynecol 2016; 55: 874-876.

18. Stanhewicz AE, Alexander LM. Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia. Am J Physiol Regul Integr Comp Physiol 2020; 318: R148-R155.